Azitra, Inc.

AZTR

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001701478

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

14

+7 vs. Q1 2026
Total value $3.63M

View 13F holders

Superinvestors holding AZTR

0

None of the superinvestors held AZTR at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by AZTR insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Mar 20, 2026	Mar 18, 2026	Salva Francisco D.President and CEO	PPurchaseCommon Stock · Derivative	+12.19M	–	–	4.06M	–	SEC
Apr 1, 20249:51 PM ET	Mar 29, 2024	Staskey NormChief Financial Officer	PPurchaseCommon Stock	+47.6K	$0.2108	+$10.03K	51.1K	+1,360.0%	SEC
Feb 15, 20248:42 PM ET	Feb 13, 2024	Whitfill TravisChief Operating Officer	PPurchaseCommon Stock	+15K	$0.30	+$4.5K	334.5K	+4.7%	SEC
Feb 15, 20248:39 PM ET	Feb 13, 2024	Staskey NormChief Financial Officer	PPurchaseCommon Stock	+3.3K	$0.30	+$990	3.5K	+1,650.0%	SEC
Feb 15, 20248:38 PM ET	Feb 13, 2024	Salva Francisco D.President and CEO	PPurchaseCommon Stock	+333.3K	$0.30	+$99.99K	338.3K	+6,666.0%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in AZTR at the end of Q2 2026.

Institutions holding AZTR in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Dauntless Investment Group, LLC	11,292,186	$1.89M	3.28%	+11,291,186+1,129,118.6%	Added
Stonepine Capital Management, LLC	5,285,476	$886.9K	0.68%	+5,285,476	New
Nantahala Capital Management, LLC	4,427,226	$742.89K	0.02%	+4,427,226	New
JANE STREET GROUP, LLC	248,433	$41.69K	0.00%	+248,433	New
GEODE CAPITAL MANAGEMENT, LLC	95,409	$16.01K	0.00%	−374,469−79.7%	Reduced